Cancer

Items 21-30 of 184

per page
Set Descending Direction
  1. B-Xpander™ CD40L (human) (multimeric) (rec.) (Animal Free)
    AG-40B-0010AF
    AG-40B-0010AF-C01010 µg
    CHF 390.00
    AG-40B-0010AF-C100100 µg
    CHF 1'800.00
    B-Xpander™ CD40L (human) (multimeric) (rec.) (Animal Free)
  2. BAFF, Soluble (mouse) (rec.)
    AG-40B-0022
    AG-40B-0022-C01010 µg
    CHF 190.00
    AG-40B-0022-30103 x 10 µg
    CHF 380.00
  3. Calreticulin (human) (rec.) (His)
    AG-40A-0132
    AG-40A-0132-C01010 µg
    CHF 230.00
    AG-40A-0132-C05050 µg
    CHF 590.00
    Flow cytometric analysis of CRT on the cell surface 3.105 EL4 Thymoma cells, growing in suspension in RPMI 1640 (Gibco) supplemented medium were plated in 12-well plates and treated with mitomycin C (30mM, Sanofi Aventis)
  4. CD112R (mouse):Fc (human) (rec.)
    AG-40B-0170
    AG-40B-0170-C01010 µg
    CHF 480.00
    AG-40B-0170-30103 x 10 µg
    CHF 960.00
    CD112R (mouse):Fc (human) (rec.)
  5. CD137 (human):Fc (human) (rec.)
    AG-40B-0060
    AG-40B-0060-C05050 µg
    CHF 310.00
    AG-40B-0060-30503 x 50 µg
    CHF 625.00
  6. CD137 (mouse):Fc (human) (rec.)
    AG-40A-0025
    AG-40A-0025-C05050 µg
    CHF 350.00
  7. CD137L, Soluble (human) (rec.)
    AG-40A-0198T
    AG-40A-0198T-C05050 µg
    CHF 420.00
    Pull down assay of hCD137L-FLAG (Prod. No. AG-40A-0198T) by hCD137-Fc. Method: 5μg of hCD137-Fc (or control Fc protein), 5μg of hCD137L-FLAG (or control FLAG protein), and protein G resin (or anti-FLAG resin) were incubated in 0.5ml
  8. CD137L, Soluble (mouse) (rec.)
    AG-40A-0020Y
    AG-40A-0020Y-C05050 µg
    CHF 420.00
    /
  9. CD152 [CTLA-4] (human) (rec.) (His)
    AG-40B-0228
    AG-40B-0228-C05050 µg
    CHF 220.00
    CD152 [CTLA-4] (human) (rec.) (His)
  10. CD152 [CTLA-4] (human) (rec.) (untagged)
    AG-40B-0232
    AG-40B-0232-C05050 µg
    CHF 220.00
    CD152 [CTLA-4] (human) (rec.) (untagged)

Items 21-30 of 184

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.